Metraipolis › archive › dc_a3e89e54fa41
Complete remission of recurrent human papillomavirus-associated cervical cancer managed with camrelizumab and nanoparticle albumin-bound paclitaxel as… — Europe PMC PMID:41409282
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41409282
- DOI
- 10.3389/fimmu.2025.1679950
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T00:37:42.496Z
- SHA-256 of the archived text
d660ae8b0e736556f98c6ad98784cecd6ba65596abd88e0682d30411bb803b63- Stable URL of this page
https://metraipolis.com/documento/dc_a3e89e54fa41
How to cite
Complete remission of recurrent human papillomavirus-associated cervical cancer managed with camrelizumab and nanoparticle albumin-bound paclitaxel as… — Europe PMC PMID:41409282 — Europe PMC (en), https://europepmc.org/article/MED/41409282 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a3e89e54fa41 (Metraipolis archive dc_a3e89e54fa41, sha256 d660ae8b0e736556f98c6ad98784cecd6ba65596abd88e0682d30411bb803b63)
BibTeX
@misc{dca3e89e54fa41,
title = {Complete remission of recurrent human papillomavirus-associated cervical cancer managed with camrelizumab and nanoparticle albumin-bound paclitaxel as… — Europe PMC PMID:41409282},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41409282},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a3e89e54fa41; sha256 d660ae8b0e736556f98c6ad98784cecd6ba65596abd88e0682d30411bb803b63},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41409282. Agents can read the archived copy with the MCP tool read_document.